High-Risk Gestational Trophoblastic Neoplasia from a Homozygous NLRP7 Mutation.

Gynecol Oncol Rep

Department of Obstetrics and Gynecology, Brooke Army Medical Center, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA.

Published: August 2021

•NLRP7 germline mutation can result in high risk gestational trophoblastic neoplasia.•No successful reproductive outcomes have been reported with homozygous NLRP7 mutation.•Germline testing should be considered for patients presenting with recurrent gestational trophoblastic disease.•Once an NLRP7 mutation is diagnosed, consultation with reproductive endocrinology is necessary to discuss future fertility.•Further research is needed in rare cases regarding gestational trophoblastic neoplasia recurrence and reproductive outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215180PMC
http://dx.doi.org/10.1016/j.gore.2021.100803DOI Listing

Publication Analysis

Top Keywords

gestational trophoblastic
16
trophoblastic neoplasia
8
homozygous nlrp7
8
nlrp7 mutation
8
reproductive outcomes
8
high-risk gestational
4
trophoblastic
4
neoplasia homozygous
4
mutation •nlrp7
4
•nlrp7 germline
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!